Evidence mapPaperPMID 39819643Full record

ArticleJournal of ovarian research2025

Woxuanzhongzhou formula improves DHEAS and high-fat diet-induced IR and anovulatory mice via AMPK/PGC1- α/Irisin pathway.

Haijuan Liu, Guohua Wang, Conglu Sui, Yanan Guo, Xiangyu He

Abstract read
In one paragraph

Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haijuan LiuDepartment of Gynecology, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, China.
Guohua WangDepartment of Gynecology, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, China. wgh1188@163.com.
Conglu SuiDepartment of Gynecology, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, China. suiconglu@126.com.
Yanan GuoDepartment of Gynecology, Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, China.
Xiangyu HeShunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, 101300, China.

Funding

Basic Research Program of Beijing University of Chinese Medicine 2018-JYBZZ-JS138Beijing University of Chinese Medicine Vertical Development Fund for University-level Research 2023-SFYZX-09the Beijing University of Chinese Medicine Key Discipline Construction Program Fund grant number 90010951310079The Third Affiliated Hospital of Beijing University of Chinese Medicine 2022 Institutional Cultivation Programs BZYSY-2022-PYMS-13
6 · The paper itself

Abstract

backgroundPolycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women of reproductive age. Anovulation is one of the most important clinical features of PCOS, and insulin resistance (IR) is one of the critical pathogenic factors. Woxuanzhongzhou (WXZZ) is a traditional herbal formulation that has shown efficacy in treating PCOS combined with IR, but the underlying mechanism is not clear. The aim of this study was to investigate the molecular mechanism of WXZZ on dehydroepiandrosterone sulfate and high fat diet induced PCOS with IR mice.

methods40 female C57BL/6 mice were randomized to 4 groups: control group, model group, metformin group, and WXZZ group. Some mice is induced by dehydroepiandrosterone sulfate (DHEA) and high-fat diet (HFD) for 3 weeks. Following model induction, metformin and WXZZ were administered by gavage. Body weight, fasting blood glucose (FBG), fasting insulin (FINS) levels, the homeostatic model assessment of insulin resistance (HOMA-IR), and gonadal hormones were measured. Estrous cycles were monitored. The structure of the gastrocnemius muscle and subcutaneous fatty tissue were also evaluated. Additionally, serum irisin and non-esterified fatty acids (NEAF) levels and the protein and gene expression levels of AMPK, PGC1-α, FNDC5, irisin in the gastrocnemius muscle and CaMKK, AMPK, PGC1-α, UCP1 in fat were analyzed.

resultsThe DHEA + HFD + WXZZ group exhibited significant improvements in several key parameters compared to the DHEA + HFD group. WXZZ ameliorated endocrine and metabolic disorders, resumed estrous cycle in DHEAS and high-fat diet-induced IR and anovulatory mice. Significant reductions were observed in body weight, serum testosterone, luteinizing hormone, luteinizing hormone/ follicle-stimulating hormone ratio, FINS, and HOMA-IR. Additionally, WXZZ promoted irisin expression and secretion by up-regulating the protein and gene AMPK/PGC1-α/FNDC5 expression in gastrocnemius muscle and up-regulated the protein and gene CaMKK/AMPK/PGC1-α/UCP1 expression in fat. WXZZ inhibited the overproduction of serum NEFA, and reduced lipid accumulation. Structural analysis of the gastrocnemius muscle and adipose tissue revealed partial restoration.

conclusionWXZZ exhibits therapeutic effects in DHEAS and high-fat diet-induced IR and anovulatory mice. These effects may be mediated through the activation of AMPK/PGC1-α pathway in muscle to promote the secretion of irisin.

Indexed as

Dehydroepiandrosterone SulfateDrugs, Chinese HerbalFibronectinsInsulin ResistancePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPolycystic Ovary SyndromeAMP-Activated Protein KinasesAnimalsDiet, High-FatDisease Models, AnimalFemaleMiceMice, Inbred C57BLSignal TransductionAMP-Activated Protein KinasesDehydroepiandrosterone SulfateDrugs, Chinese HerbalFibronectinsFNDC5 protein, mousePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseAMPKFNDC5Insulin resistanceIrisinPGC1-αPolycystic ovary syndrome

Identifiers

PMID39819643
PMCPMC11737048

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.